Method for preparing agomelatine cocrystals and composition containing same

US9795574B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9795574-B2
Application numberUS-201515323063-A
CountryUS
Kind codeB2
Filing dateJun 30, 2015
Priority dateJun 30, 2014
Publication dateOct 24, 2017
Grant dateOct 24, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a preparation method for agomelatine-resorcinol and agomelatine-hydroquinone co-crystals using the solvent-antisolvent method that enables a commercial mass production. The co-crystals prepared by the preparation method of the present invention displays high dissolution rate and high stability in acidic-to-neutral media.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for preparing agomelatine-resorcinol or agomelatine-hydroquinone co-crystals, the method comprising: (i) dissolving agomelatine and one aromatic polyhydric alcohol selected from hydroquinone and resorcinol in an organic solvent selected from the group consisting of C3-C7 ester, C2-C7 ether and a mixture thereof to prepare a solution; and (ii) adding a solvent selected from the group consisting of C5-C7 alkane, benzene and a mixture thereof as an antisolvent to the solution of the step (i) to prepare a mixture. 2. The method of claim 1 , wherein the agomelatine-resorcinol co-crystal has a powder X-ray diffraction pattern showing peaks (±0.2°) at Bragg angles (2 theta) of 7.25°, 7.95°, 8.35°, 14.45°, 16.70°, 17.35°, 17.95°, 19.05°, 19.95°, 21.30°, 21.75°, 22.50°, 23.75°, and 24.40°. 3. The method of claim 1 , wherein the agomelatine-resorcinol co-crystal has a single endothermic peak in the differential scanning calorimetry (DSC) curve at 88° C. 4. The method of claim 1 , wherein the agomelatine-hydroquinone co-crystal has a powder X-ray diffraction pattern showing peaks (±0.2°) at Bragg angles (2 theta) of 10.40°, 17.00°, 17.50°, 18.00°, 19.25°, 20.10°, 21.00°, 21.30°, 21.75°, 22.10°, 23.55°, 24.15°, and 26.20°. 5. The method of claim 1 , wherein the agomelatine-hydroquinone co-crystal has a single endothermic peak in the differential scanning calorimetry (DSC) curve at 97° C. 6. The method of claim 1 , wherein the solution comprises agomelatine and resorcinol or hydroquinone at a molar ratio of 1:1 to 1:2. 7. The method of claim 1 , wherein the organic solvent is at least one selected from the group consisting of methylacetate, ethylacetate, diethylether, methyl-tert-butylether, and a mixture thereof. 8. The method of claim 1 , wherein the antisolvent is at least one selected from the group consisting of pentane, hexane, heptane, benzene, and a mixture thereof. 9. The method of claim 1 , further comprising: stirring the mixture of the step (ii).

Assignees

Inventors

Classifications

  • Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent · CPC title

  • having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton · CPC title

  • from compounds not provided for in groups C07C231/02 - C07C231/08 · CPC title

  • Crystalline forms, e.g. polymorphs · CPC title

  • A61K31/165Primary

    having aromatic rings, e.g. colchicine, atenolol, progabide · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9795574B2 cover?
The present invention provides a preparation method for agomelatine-resorcinol and agomelatine-hydroquinone co-crystals using the solvent-antisolvent method that enables a commercial mass production. The co-crystals prepared by the preparation method of the present invention displays high dissolution rate and high stability in acidic-to-neutral media.
Who is the assignee on this patent?
Univ Soonchunhyang Ind Acad Coop Found
What technology area does this patent fall under?
Primary CPC classification A61K31/165. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).